HsiuChuan Yang - EirGenix Head CFO
| 6589 Stock | TWD 88.60 2.00 2.31% |
CFO
HsiuChuan Yang is Head CFO of EirGenix
| Phone | 886 2 7708 0123 |
| Web | https://www.eirgenix.com |
EirGenix Management Efficiency
The company has return on total asset (ROA) of (0.0168) % which means that it has lost $0.0168 on every $100 spent on assets. This is way below average. EirGenix's management efficiency ratios could be used to measure how well EirGenix manages its routine affairs as well as how well it operates its assets and liabilities. EirGenix Inc. operates as a contract development and manufacturing company worldwide. Its services include cell line development, process development, analytical sciences and quality control, cGMP manufacturing, and antibody drug conjugate. EIRGENIX INC operates under Biotechnology classification in Taiwan and is traded on Taiwan OTC Exchange. It employs 179 people. EirGenix (6589) is traded on Taiwan OTC Exchange in Taiwan and employs 20 people.Management Performance
| Return On Equity | -5.0E-4 | |||
| Return On Asset | -0.0168 |
EirGenix Leadership Team
Elected by the shareholders, the EirGenix's board of directors comprises two types of representatives: EirGenix inside directors who are chosen from within the company, and outside directors, selected externally and held independent of EirGenix. The board's role is to monitor EirGenix's management team and ensure that shareholders' interests are well served. EirGenix's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, EirGenix's outside directors are responsible for providing unbiased perspectives on the board's policies.
| ChihJung Chang, Chief Operating Officer, Chief Manufacturing Officer, Deputy General Manager | ||
| AeNing Lin, Ex Control | ||
| ShangChung Ju, Ex Officer | ||
| HsiuChuan Yang, Head CFO | ||
| Thomas Schulze, Deputy General Manager | ||
| LeeCheng Liu, General Manager, Chief of Research & Development Officer, Director |
EirGenix Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is EirGenix a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -5.0E-4 | |||
| Return On Asset | -0.0168 | |||
| Profit Margin | (0) % | |||
| Operating Margin | (0.17) % | |||
| Current Valuation | 39.51 B | |||
| Shares Outstanding | 304.26 M | |||
| Shares Owned By Insiders | 33.40 % | |||
| Shares Owned By Institutions | 14.15 % | |||
| Price To Book | 4.38 X | |||
| Price To Sales | 25.64 X |
Pair Trading with EirGenix
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if EirGenix position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EirGenix will appreciate offsetting losses from the drop in the long position's value.Moving against EirGenix Stock
| 0.69 | 2888 | Shin Kong Financial Earnings Call This Week | PairCorr |
| 0.53 | 2891C | CTBC Financial Holding | PairCorr |
| 0.52 | 6547 | Medigen Vaccine Biologics | PairCorr |
| 0.5 | 4743 | Oneness Biotech | PairCorr |
| 0.48 | 4142 | Adimmune Corp | PairCorr |
The ability to find closely correlated positions to EirGenix could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace EirGenix when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back EirGenix - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling EirGenix to buy it.
The correlation of EirGenix is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as EirGenix moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if EirGenix moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for EirGenix can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for EirGenix Stock Analysis
When running EirGenix's price analysis, check to measure EirGenix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EirGenix is operating at the current time. Most of EirGenix's value examination focuses on studying past and present price action to predict the probability of EirGenix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EirGenix's price. Additionally, you may evaluate how the addition of EirGenix to your portfolios can decrease your overall portfolio volatility.